Correlation Between Insuline Medical and Migdal Insurance

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Insuline Medical and Migdal Insurance at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Insuline Medical and Migdal Insurance into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Insuline Medical and Migdal Insurance, you can compare the effects of market volatilities on Insuline Medical and Migdal Insurance and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Insuline Medical with a short position of Migdal Insurance. Check out your portfolio center. Please also check ongoing floating volatility patterns of Insuline Medical and Migdal Insurance.

Diversification Opportunities for Insuline Medical and Migdal Insurance

-0.58
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Insuline and Migdal is -0.58. Overlapping area represents the amount of risk that can be diversified away by holding Insuline Medical and Migdal Insurance in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Migdal Insurance and Insuline Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Insuline Medical are associated (or correlated) with Migdal Insurance. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Migdal Insurance has no effect on the direction of Insuline Medical i.e., Insuline Medical and Migdal Insurance go up and down completely randomly.

Pair Corralation between Insuline Medical and Migdal Insurance

Assuming the 90 days trading horizon Insuline Medical is expected to under-perform the Migdal Insurance. In addition to that, Insuline Medical is 3.63 times more volatile than Migdal Insurance. It trades about -0.05 of its total potential returns per unit of risk. Migdal Insurance is currently generating about 0.36 per unit of volatility. If you would invest  60,930  in Migdal Insurance on September 5, 2024 and sell it today you would earn a total of  7,520  from holding Migdal Insurance or generate 12.34% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Insuline Medical  vs.  Migdal Insurance

 Performance 
       Timeline  
Insuline Medical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Insuline Medical has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Insuline Medical is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Migdal Insurance 

Risk-Adjusted Performance

37 of 100

 
Weak
 
Strong
Very Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Migdal Insurance are ranked lower than 37 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Migdal Insurance sustained solid returns over the last few months and may actually be approaching a breakup point.

Insuline Medical and Migdal Insurance Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Insuline Medical and Migdal Insurance

The main advantage of trading using opposite Insuline Medical and Migdal Insurance positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Insuline Medical position performs unexpectedly, Migdal Insurance can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Migdal Insurance will offset losses from the drop in Migdal Insurance's long position.
The idea behind Insuline Medical and Migdal Insurance pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Other Complementary Tools

Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume